Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
Compare the progression-free survival (PFS) of treatment-naïve patients with mRCC receiving AG-013736 vs sorafenib. Estimate the progression-free survival (PFS) of previously-treated Asian patients with mRCC receiving AG-013736 vs sorafenib.
Inclusion criteria
- metastatic renal cell cancer